A novel role for an established player: anemia drug erythropoietin for the 
treatment of cerebral hypoxia/ischemia

Ehrenreich, Hannelore; Timner, Wiebke; Siren, Anna-Leena

Item

ITEM ACTIONSEXPORT

Add to Basket

Local TagsRelease HistoryDetailsSummary

Released

Journal Article

A novel role for an established player: anemia drug erythropoietin for the treatment of cerebral hypoxia/ischemia

MPS-Authors

/persons/resource/persons182138

Ehrenreich, Hannelore
Clinical neuroscience, Max Planck Institute of Experimental Medicine, Max Planck Society;

/persons/resource/persons182451

Timner, Wiebke
Clinical neuroscience, Max Planck Institute of Experimental Medicine, Max Planck Society;

/persons/resource/persons182411

Siren, Anna-Leena
Clinical neuroscience, Max Planck Institute of Experimental Medicine, Max Planck Society;

External Resource

No external resources are shared

Fulltext (restricted access)

There are currently no full texts shared for your IP range.

Fulltext (public)

There are no public fulltexts stored in PuRe

Supplementary Material (public)

There is no public supplementary material available

Citation

Ehrenreich, H., Timner, W., & Siren, A.-L. (2004). A novel role for an established player: anemia drug erythropoietin for the treatment of cerebral hypoxia/ischemia. Transfusion and Apheresis Science, 31(1), 39-44.

Cite as: https://hdl.handle.net/11858/00-001M-0000-0029-30BA-F

Abstract

There is no abstract available